Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients with glioma.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patient inclusion:
Caregiver Inclusion:
Exclusion criteria
Patient:
Caregiver:
Primary purpose
Allocation
Interventional model
Masking
22 participants in 3 patient groups
Loading...
Central trial contact
Autumn Lanoye, PhD; Ashlee Loughan, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal